Publication | Open Access

A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma

MedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyHuman PlasmaUhplc–ms/ms MethodInfection ControlAntiviral DrugPharmacologyAntiviral CompoundViral Immunity